CDT MEXC RealStocks
Own real CDT shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 02:28:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
CDT Equity Inc. (CDT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.35, with a market capitalization of $383.73K and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.33 to $291,250.00. This page covers its latest market performance, valuation, price trends and company information.
$383.73K | |
$0.35 | |
$0.38 | |
$0.33 | |
$0.36 | |
196.32K | |
916.09K | |
-- | |
$291,250.00 | |
$0.33 | |
-- | |
2026-06-30 |
CDT Equity Inc. (CDT) last closed at $0.35 as of 2026-11-19 01:00:00, down 2.39% ($0.01) from the previous close of $0.36.
During the latest regular trading session, CDT traded between $0.33 and $0.38, with a volume of 196.32K shares. The closing price was near the middle and near the lower end of its 52-week range.
Over the past seven days, CDT Equity Inc. (CDT) moved from $0.84 to $0.35, representing a decline of 58.22% ($0.49).
The stock traded between $0.33 and $1.08 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.10 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.0%
CDT is currently trading at $0.35, placing it 0.0% of the way from its 52-week low of $0.33 to its 52-week high of $291,250.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 4 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for CDT Equity Inc.
Stock Split | |
|---|---|
| Split Date | Nov 6, 2026 |
| Split Ratio | 1-for-20 |
Eligible investors can buy real shares of CDT Equity Inc. (CDT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to CDT, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between CDT shares and USD.
CDT Shares to USD
1.00 CDT shares = 0.351 USD
Calculations are estimates based on the latest available price and are for reference only.